The global necrotizing gingivostomatitis treatment market size is estimated to reach ~USD 34 Million by the end of 2035 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2035. In addition to this, in the year 2022, the market size of necrotizing gingivostomatitis treatment was ~USD 15 Million. The growth of the market can be attributed to the increasing prevalence of gingivostomatitis in children across the world. The growing incidence of bacterial growth in the mouth owing to a lack of oral health habits is estimated to boost the market growth. Not brushing and flossing teeth on daily basis owing to a lack of awareness and education among illiterate people is expected to fuel the market growth in the coming years. More than 70% of the American population brush their teeth only once a day as per the estimations in 2021.
The habit of oral sex with the infected person is also estimated to increase the risk of occurrence of gingivostomatitis in the people which thereby hike the market growth across the world. The growing use of antibiotics and over-the-counter (OTC) drugs for minor oral sores and injuries is also estimated to drive market growth. The market growth is also attributed to the increasing prevalence of HIV among adults owing to multiple sex partners or sex with an infected person. HIV makes the patient immunosuppressant leading to the incidence of more infections. According to the reports, the number of people in the U.S. living with HIV was estimated to be more than 1 million with over 33,000 new infections per annum during 2021.
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~7% |
|
Base Year Market Size (2022) |
~ USD 15 Million |
|
Forecast Year Market Size (2035) |
~ USD 34 Million |
|
Regional Scope |
|
Growth Drivers
More than 0.4% to 10% of the population around the globe are affected by trench mouth or necrotizing gingivostomatitis and are around the age of 18 to 20 years as per the 2022 reports.
Challenges
The increasing use of side effects of antibiotics includes rash, dizziness, diarrhea, nausea, and yeast infections. Also, other serious side effects include Clostridioides difficile infection that leads to diarrhea and severe colon damage, and eventually death. These side effects of medications are estimated to hamper the market growth in the coming years.
The global necrotizing gingivostomatitis treatment market is segmented and analyzed for demand and supply by type into necrotizing ulcerative gingivitis (NUG), necrotizing ulcerative periodontitis (NUP), and necrotizing stomatitis (NS). Out of the three types, the necrotizing ulcerative periodontitis segment is estimated to gain the largest market share of about ~38% in the year 2035. The growth of the segment can be attributed to the increasing number of people who smoke regularly across the world. The growing stress, anxiety, and sleep deprivation are also estimated to rise the market growth. Over 75% of people across the U.S. are estimated to feel stress that causes physical illness as of 2022 reports. The use of antiseptic mouthwashes or oral antibiotics is used for the treatment of necrotizing ulcerative periodontitis. The practice of oral hygiene with oral medication and proper diet is believed to help during the recovery time of patients. The increasing consumption of antibiotics by most people across the globe as the first line of drug therapy is anticipated to drive market segment growth in the coming years. The list of antibiotics that are used in the treatment procedure includes amoxicillin, metronidazole, clavulanate, tetracyclines, and penicillins. The lack of awareness about hygienic practices and not maintaining any routine to prevent gum diseases is also estimated to fuel the growth of the market segment.
The global necrotizing gingivostomatitis treatment market is also segmented and analyzed for demand and supply by treatment into antiseptic rinses, antibiotics, gingival grafting, and others. Amongst these segments, the antiseptic rinses segment is expected to garner a significant share of around ~32% in the year 2035. The Increasing number of cases of drinking alcohol and chewing tobacco or smoking is estimated to drive the market growth. The use of antiseptic rinses is the best way to prevent or reduce the infection as it cleanses the bacteria grown on the surface without worsening further. The antiseptic rinses after brushing and eating remove harmful bacteria or microorganisms cleaning the area of infected gums. Antiseptic rinses help to regulate the formation of plaque and disrupt the bacteria in the mouth.
Our in-depth analysis of the global necrotizing gingivostomatitis treatment market includes the following segments:
|
By Type |
|
|
By Treatment |
|
|
By Distribution Channel |
|
The market share of necrotizing gingivostomatitis treatment in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~39% by the end of 2035. The growth of the market can be attributed majorly to the high prevalence of lifestyle diseases, caused by inactive routines, busy lifestyles, and unhealthy eating habits. According to data from the Centers for Disease Control and Prevention, over 45% of Americans suffer from at least one chronic disease in the U.S. The increasing preference for outside food and a growing number of people eating ready-made and fast foods owing to the growing working population is estimated to propel the market growth in the coming years. Also, an improper diet with no nutrients is estimated to drive market growth. The increasing number of people consuming spicy foods that do not contain any nutritional value is estimated to boost the market growth. Intake of food with no proper proteins or vitamins and increasing changes in eating habits also drive the market growth.
The European necrotizing gingivostomatitis treatment market is estimated to be the second largest, registering a share of about ~22% by the end of 2035. The growth of the market can be attributed majorly to the largely Caucasian population, and the poor lifestyle of the people in developed nations. Over 50 million people in Europe suffer from chronic conditions. The rising number of people suffering from immune suppressive disorders across the region owing to aging and genetic disorders is estimated to drive the growth of the market. Unhygienic healthcare habits such as not washing hands after using restrooms are also estimated to propel the market growth in the coming years. Increasing preference for fast foods as they taste good and do not require much time for preparation as more people started working jobs is also estimated to drive the market growth during the forecast period. Also, the market growth is attributed to many people in the region suffering from periodontitis with increasing incidence in the elder population. The cost of oral health services is very high in the region which is estimated to drive the market growth.
Further, the market in the Asia Pacific, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the rising dehydration among people owing to a lack of concentration on health and more involvement in work. The growing number of people with mouth ulcers and blisters caused by stress and sleep deprivation is expected to fuel the market growth. The increasing number of people suffering from gum diseases owing to the lack of education in some countries leads to the development of serious infections causing gingivostomatitis which is estimated to hike the market growth. Also, using the same razors unknowingly by local barber shops and the same makeup products by beauticians increases the chances of disease occurrence which in turn propels the market growth. The lack of government programs to educate the slum areas about the complications caused by not washing hands after using public toilets is estimated to propel the market growth.
GlaxoSmithKline plc conducted an online survey in five European countries with 4,500 people to study the relationship between poor oral hygiene and disease complications. The conclusion of the study showed that there was a need to raise public awareness regarding the impact of oral hygiene on overall health.
Aviro Health L.P. declared that it granted the award of investigator-initiated research (IIR) grant to the University of Pennsylvania School of Dental Medicine Center for Clinical and Translational Research to investigate and report the effectiveness of povidone-iodine antiseptic oral rinse in removing COVID-19 virus or SARS-CoV-2 virus in the mouth.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?